Found: 6
Select item for more details and to access through your institution.
Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 476, p. N.PAG, doi. 10.1126/scitranslmed.aat1199
- By:
- Publication type:
- Article
GATA6 mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm.
- Published in:
- eLife, 2020, p. 1, doi. 10.7554/eLife.53278
- By:
- Publication type:
- Article
Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-26889-2
- By:
- Publication type:
- Article
Revisiting Frank-Starling: regulatory light chain phosphorylation alters the rate of force redevelopment ( k<sub>tr</sub>) in a length-dependent fashion.
- Published in:
- Journal of Physiology, 2016, v. 594, n. 18, p. 5237, doi. 10.1113/JP272441
- By:
- Publication type:
- Article
Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle.
- Published in:
- Experimental Physiology, 2024, v. 109, n. 2, p. 175, doi. 10.1113/EP090436
- By:
- Publication type:
- Article
Hierarchical and stage-specific regulation of murine cardiomyocyte maturation by serum response factor.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06347-2
- By:
- Publication type:
- Article